OMF Kynurenine trial

Messages
80
Likes
179
Daily administration of BB536 was found .. to decrease the resting level of plasma corticosterone and the ratio of kynurenine to tryptophan.
Wouldn’t the goal be to increase the ratio of Kyn to Trp? We want more Kyn and less Trp. Or am I misunderstanding something?
 
Last edited: